Caitlin Cronin
Stock Analyst at Canaccord Genuity
(3.88)
# 620
Out of 5,132 analysts
47
Total ratings
48.57%
Success rate
13.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Caitlin Cronin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Buy | $105 → $112 | $88.09 | +27.14% | 3 | Jan 9, 2026 | |
| ENOV Enovis | Maintains: Buy | $58 → $50 | $21.77 | +129.67% | 4 | Dec 17, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $14.30 | +4.90% | 6 | Dec 17, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $72 → $85 | $74.60 | +13.94% | 3 | Dec 17, 2025 | |
| AXGN Axogen | Maintains: Buy | $27 → $37 | $33.24 | +11.31% | 8 | Dec 5, 2025 | |
| TELA TELA Bio | Maintains: Buy | $7 → $4 | $0.79 | +406.91% | 5 | Nov 18, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $36 → $34 | $36.18 | -6.03% | 4 | Nov 11, 2025 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 → $25 | $13.36 | +87.13% | 5 | Oct 31, 2025 | |
| VCEL Vericel | Maintains: Buy | $61 → $58 | $35.96 | +61.29% | 4 | Aug 1, 2025 | |
| BVS Bioventus | Maintains: Buy | $15 | $8.27 | +81.38% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $4.64 | -13.79% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $130 | $96.45 | +34.78% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $270 → $12 | $1.82 | +559.34% | 1 | Nov 14, 2023 |
Globus Medical
Jan 9, 2026
Maintains: Buy
Price Target: $105 → $112
Current: $88.09
Upside: +27.14%
Enovis
Dec 17, 2025
Maintains: Buy
Price Target: $58 → $50
Current: $21.77
Upside: +129.67%
InMode
Dec 17, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $14.30
Upside: +4.90%
Establishment Labs Holdings
Dec 17, 2025
Maintains: Buy
Price Target: $72 → $85
Current: $74.60
Upside: +13.94%
Axogen
Dec 5, 2025
Maintains: Buy
Price Target: $27 → $37
Current: $33.24
Upside: +11.31%
TELA Bio
Nov 18, 2025
Maintains: Buy
Price Target: $7 → $4
Current: $0.79
Upside: +406.91%
Smith & Nephew
Nov 11, 2025
Maintains: Hold
Price Target: $36 → $34
Current: $36.18
Upside: -6.03%
Alphatec Holdings
Oct 31, 2025
Maintains: Buy
Price Target: $20 → $25
Current: $13.36
Upside: +87.13%
Vericel
Aug 1, 2025
Maintains: Buy
Price Target: $61 → $58
Current: $35.96
Upside: +61.29%
Bioventus
Mar 17, 2025
Maintains: Buy
Price Target: $15
Current: $8.27
Upside: +81.38%
Nov 14, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $4.64
Upside: -13.79%
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $96.45
Upside: +34.78%
Nov 14, 2023
Downgrades: Hold
Price Target: $270 → $12
Current: $1.82
Upside: +559.34%